BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25194449)

  • 21. Clinical outcomes of long-acting risperidone in recent versus long-term diagnosed Belgian schizophrenic patients: results from electronic Schizophrenia Treatment Adherence Registry (e-STAR) and Trial for the Initiation and Maintenance Of REmission in Schizophrenia with risperidone (TIMORES).
    Dubois V; Peuskens J; Geerts P; Detraux J
    Early Interv Psychiatry; 2014 Feb; 8(1):39-49. PubMed ID: 23343330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of a functional remission threshold for the Functional Remission of General Schizophrenia (FROGS) scale.
    Boyer L; Richieri R; Guedj E; Faget-Agius C; Loundou A; Llorca PM; Auquier P; Lançon C
    Compr Psychiatry; 2013 Oct; 54(7):1016-22. PubMed ID: 23731897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study.
    San L; Ciudad A; Alvarez E; Bobes J; Gilaberte I
    Eur Psychiatry; 2007 Nov; 22(8):490-8. PubMed ID: 17904337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The concurrent and predictive validity of symptomatic remission criteria in first-episode schizophrenia.
    Chang WC; Chan TC; Chen ES; Hui CL; Wong GH; Chan SK; Lee EH; Chen EY
    Schizophr Res; 2013 Jan; 143(1):107-15. PubMed ID: 23151398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Quality of life in patients with schizophrenia: a study of 100 cases].
    Zouari L; Thabet JB; Elloumi Z; Elleuch M; Zouari N; Maâlej M
    Encephale; 2012 Apr; 38(2):111-7. PubMed ID: 22516268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remission in schizophrenia: results from a 1-year follow-up observational study.
    Ciudad A; Alvarez E; Bobes J; San L; Polavieja P; Gilaberte I
    Schizophr Res; 2009 Mar; 108(1-3):214-22. PubMed ID: 19168329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptomatic remission and neurocognitive functioning in patients with schizophrenia.
    Hofer A; Bodner T; Kaufmann A; Kemmler G; Mattarei U; Pfaffenberger NM; Rettenbacher MA; Trebo E; Yalcin N; Fleischhacker WW
    Psychol Med; 2011 Oct; 41(10):2131-9. PubMed ID: 21426601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A structural equation modelling approach to explore the determinants of quality of life in schizophrenia.
    Alessandrini M; Lançon C; Fond G; Faget-Agius C; Richieri R; Faugere M; Metairie E; Boucekine M; Llorca PM; Auquier P; Boyer L
    Schizophr Res; 2016 Mar; 171(1-3):27-34. PubMed ID: 26781001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of early stable symptomatic remission after an exacerbation of schizophrenia: the significance of symptoms, neuropsychological performance and cognitive biases.
    Andreou C; Roesch-Ely D; Veckenstedt R; Bohn F; Aghotor J; Köther U; Pfueller U; Moritz S
    Psychiatry Res; 2013 Dec; 210(3):729-34. PubMed ID: 23998362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.
    Brissos S; Dias VV; Carita AI; Martinez-Arán A
    Psychiatry Res; 2008 Jul; 160(1):55-62. PubMed ID: 18485488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symptomatic remission affects employment outcomes in schizophrenia patients.
    Wang SP; Wang JD; Chang JH; Wu BJ; Wang TJ; Sun HJ
    BMC Psychiatry; 2020 May; 20(1):219. PubMed ID: 32398138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia.
    Lambert M; Schimmelmann BG; Naber D; Schacht A; Karow A; Wagner T; Czekalla J
    J Clin Psychiatry; 2006 Nov; 67(11):1690-7. PubMed ID: 17196047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is going into stable symptomatic remission associated with a more positive development of life satisfaction? A 10-year follow-up study of first episode psychosis.
    Gardsjord ES; Romm KL; Røssberg JI; Friis S; Barder HE; Evensen J; Haahr U; Ten Velden Hegelstad W; Joa I; Johannessen JO; Langeveld J; Larsen TK; Opjordsmoen S; Rund BR; Simonsen E; Vaglum P; McGlashan T; Melle I
    Schizophr Res; 2018 Mar; 193():364-369. PubMed ID: 28701275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The assessment of quality of life in clinical practice in patients with schizophrenia.
    Karow A; Wittmann L; Schöttle D; Schäfer I; Lambert M
    Dialogues Clin Neurosci; 2014 Jun; 16(2):185-95. PubMed ID: 25152657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of two alternative schizophrenia remission definitions: relationship to clinical and quality of life outcomes.
    Dunayevich E; Sethuraman G; Enerson M; Taylor CC; Lin D
    Schizophr Res; 2006 Sep; 86(1-3):300-8. PubMed ID: 16860974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remission criteria and functional outcome in patients with schizophrenia, a longitudinal study.
    Heering HD; Janssens M; Boyette LL; van Haren NE;
    Aust N Z J Psychiatry; 2015 Mar; 49(3):266-74. PubMed ID: 25406458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea.
    Lee NY; Kim SH; Cho SJ; Chung YC; Jung IK; Kim CY; Kim DH; Lee DG; Lee YH; Lim WJ; Na YS; Shin SE; Woo JM; Yoon JS; Yoon BH; Ahn YM; Kim YS
    Int Clin Psychopharmacol; 2014 Sep; 29(5):279-87. PubMed ID: 24583566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Socio-demographic and clinical correlates of subjective quality of life among Nigerian outpatients with schizophrenia.
    Adelufosi AO; Ogunwale A; Abayomi O; Mosanya JT
    Psychiatry Res; 2013 Oct; 209(3):320-5. PubMed ID: 23452754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between symptomatic remission and functional outcome in first-episode schizophrenia.
    Bodén R; Sundström J; Lindström E; Lindström L
    Schizophr Res; 2009 Feb; 107(2-3):232-7. PubMed ID: 18957275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.